Skip to main content
Menu

Select a tool from the sidebar

Portfolio
Loading...
AbbVie Inc. (ABBV)
ABBV
AbbVie Inc. (ABBV)
271.3600 $
+4.6700 (%+1.75)

ABBV: AbbVie Inc. Stock Live Price Graph

AbbVie Inc. stock live price (US Dollar), charts and analysis. Get ABBV stock market news.

AbbVie Inc. (ABBV)

Loading chart...

Industry
NYSE
Sector
-
Exchange
New York Stock Exchange

About the company

AbbVie Inc. is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and commercialization of advanced medicines. Its extensive therapeutic portfolio encompasses several key areas: Immunology and Inflammation: Leading products include HUMIRA, an injectable therapy for autoimmune and intestinal Behçet's diseases; SKYRIZI, which addresses moderate to severe plaque psoriasis in adults; and RINVOQ, a JAK inhibitor for moderate to severe active rheumatoid arthritis in adult patients. Oncology and Hematology: For blood cancers, AbbVie provides IMBRUVICA and VENCLEXTA (a BCL-2 inhibitor), both indicated for adult patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). Virology: MAVYRET offers a treatment option for individuals with chronic HCV genotype 1-6 infection. Gastroenterology and Endocrinology: The company supplies CREON, an enzyme replacement therapy for exocrine pancreatic insufficiency, and Synthroid, used to manage hypothyroidism. Linzess/Constella helps treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation. Women's Health and Urology: Lupron serves as a palliative treatment for conditions like advanced prostate cancer, endometriosis, central precocious puberty, and anemia caused by uterine fibroids. ORILISSA, a nonpeptide small molecule GnRH antagonist, is designed for women experiencing moderate to severe endometriosis pain. Neurology: AbbVie offers Duopa and Duodopa, a levodopa-carbidopa intestinal gel for Parkinson's disease, and Ubrelvy to treat migraines (with or without aura) in adults. The therapeutic formulation of Botox is also part of its offerings. Ophthalmology: Its eye care segment features Lumigan/Ganfort (a bimatoprost ophthalmic solution) and Alphagan/Combigan (an alpha-adrenergic receptor agonist), both aimed at reducing elevated intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension. Restasis, a calcineurin inhibitor immunosuppressant, is provided to enhance tear production, alongside other specialized eye care products. AbbVie Inc. also engages in research collaborations, including a partnership with Dragonfly Therapeutics, Inc. The company was founded in 2012 and operates from its headquarters in North Chicago, Illinois.

Company profile

Employees
57,000
Field of activity
Drug Manufacturers - General

Market News & Analysis

Dividend History

Cash dividends

Latest dividend (gross per share)
$1.73
Highest dividend $1.73
Average dividend $1.0563
Lowest dividend $0.4
PaymentGross / shareNet / shareYieldPer 1,000 TRY
-$1.73$1.732.55%-
-$1.73$1.732.80%-
-$1.73$1.733.23%-
-$1.73$1.733.10%-
-$1.64$1.642.90%-

What Is ABBV? Live ABBV Prices and Analysis

AbbVie Inc. (ABBV) is a global biopharmaceutical company that emerged from Abbott Laboratories in 2013. Known for its robust portfolio, AbbVie specializes in the research and development of innovative therapies, particularly in immunology, oncology, and neuroscience. Investors closely monitor ABBV due to its strong market presence, significant research capabilities, and a solid pipeline of products, making it a key player in the healthcare sector.

As a major pharmaceutical entity, AbbVie plays a crucial role in the economy by providing life-saving medications and contributing to employment in the healthcare industry. Its performance is often scrutinized by investors, analysts, and market watchers alike, given the increasing demand for advanced medical solutions.

Frequently asked questions

What is the ABBV stock price?

The latest ABBV (AbbVie Inc. (ABBV)) stock price is 271.3600 USD. Follow the live quote and chart on this page for real-time updates.

What are ABBV's intraday ceiling and floor prices?

For ABBV, the intraday ceiling is 274.9400 USD and the floor is 266.8900 USD. These levels may update during the session.

What is ABBV's previous closing price?

The previous closing price for ABBV is 266.6900 USD.

What is ABBV's trading volume?

The current trading volume for ABBV is 5,475,359. Volume can change throughout the session.

Where can I see the live ABBV price?

You can follow the live ABBV (AbbVie Inc. (ABBV)) price in the quote area and chart at the top of this Investvio overview page.

Where can I see ABBV historical prices and charts?

The current price chart for ABBV (AbbVie Inc. (ABBV)) is on this overview page. For longer historical prices and archive data, open the Archive tab and choose a period to review past performance.